Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bremelanotide: First Approval
Sohita Dhillon, Susan J. Keam
Drugs (2019) Vol. 79, Iss. 14, pp. 1599-1606
Closed Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Therapeutic peptides: current applications and future directions
Lei Wang, Nanxi Wang, Wenping Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 1163
Cyclic Peptides for Drug Development
Xinjian Ji, Alexander L. Nielsen, Christian Heinis
Angewandte Chemie International Edition (2023) Vol. 63, Iss. 3
Open Access | Times Cited: 143
Exploring FDA-Approved Frontiers: Insights into Natural and Engineered Peptide Analogues in the GLP-1, GIP, GHRH, CCK, ACTH, and α-MSH Realms
Othman Al Musaimi
Biomolecules (2024) Vol. 14, Iss. 3, pp. 264-264
Open Access | Times Cited: 18
Strategies to improve the physicochemical properties of peptide-based drugs
Michelle Felicia Lee, Chit Laa Poh
Pharmaceutical Research (2023) Vol. 40, Iss. 3, pp. 617-632
Closed Access | Times Cited: 36
Targeting the central melanocortin system for the treatment of metabolic disorders
Patrick Sweeney, Luis E. Gimenez, Ciria C. Hernández, et al.
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 9, pp. 507-519
Closed Access | Times Cited: 31
Asymmetric Synthesis of US-FDA Approved Drugs over Five Years (2016–2020): A Recapitulation of Chirality
T. N. Rekha, Dongyun Shin
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 339-339
Open Access | Times Cited: 24
2019 FDA TIDES (Peptides and Oligonucleotides) Harvest
Danah Al Shaer, Othman Al Musaimi, Fernando Alberício, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 3, pp. 40-40
Open Access | Times Cited: 65
Novel Emerging Therapies for Erectile Dysfunction
Soyeun Kim, Min Chul Cho, Sung Yong Cho, et al.
The World Journal of Men s Health (2020) Vol. 39, Iss. 1, pp. 48-48
Open Access | Times Cited: 51
Structural insights into ligand recognition and activation of the melanocortin-4 receptor
Huibing Zhang, Li-Nan Chen, Dehua Yang, et al.
Cell Research (2021) Vol. 31, Iss. 11, pp. 1163-1175
Open Access | Times Cited: 48
The melanocortin-3 receptor is a pharmacological target for the regulation of anorexia
Patrick Sweeney, Michelle N. Bedenbaugh, J. Maldonado, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 590
Open Access | Times Cited: 47
Efficient aqueous remote loading of peptides in poly(lactic-co-glycolic acid)
Morgan Giles, Justin K. Y. Hong, Yayuan Liu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 31
Medical Treatment of Female Sexual Dysfunction
Rossella E. Nappi, Lara Tiranini, Ellis Martini, et al.
Urologic Clinics of North America (2022) Vol. 49, Iss. 2, pp. 299-307
Closed Access | Times Cited: 28
Alpha-Melanocyte-Stimulating Hormone-Mediated Appetite Regulation in the Central Nervous System
Qiwen Wu, Chen Jing-mei, Tingyu Hua, et al.
Neuroendocrinology (2023) Vol. 113, Iss. 9, pp. 885-904
Open Access | Times Cited: 21
New drug approvals for 2019: Synthesis and clinical applications
Shuo Yuan, Bin Yu, Hong‐Min Liu
European Journal of Medicinal Chemistry (2020) Vol. 205, pp. 112667-112667
Closed Access | Times Cited: 49
Sexual Health after a Breast Cancer Diagnosis: Addressing a Forgotten Aspect of Survivorship
Suneela Vegunta, Carol L. Kuhle, Jennifer A. Vencill, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 22, pp. 6723-6723
Open Access | Times Cited: 25
Bremelanotide for Treatment of Female Hypoactive Sexual Desire
Amber N. Edinoff, Nicole M. Sanders, Kyle B. Lewis, et al.
Neurology International (2022) Vol. 14, Iss. 1, pp. 75-88
Open Access | Times Cited: 23
Low resting metabolic rate and increased hunger due to β-MSH and β-endorphin deletion in a canine model
Marie T. Dittmann, Gabriella Lakatos, Jodie Wainwright, et al.
Science Advances (2024) Vol. 10, Iss. 10
Open Access | Times Cited: 5
Cyclic peptides: a powerful instrument for advancing biomedical nanotechnologies and drug development
Paul Cristian Martian, Mihaela Tertiş, Denisa Leonte, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 252, pp. 116488-116488
Open Access | Times Cited: 5
Bremelanotide: New Drug Approved for Treating Hypoactive Sexual Desire Disorder
Danielle Mayer, Sarah Lynch
Annals of Pharmacotherapy (2020) Vol. 54, Iss. 7, pp. 684-690
Closed Access | Times Cited: 35
Cyclic Peptides for Drug Development
Xinjian Ji, Alexander L. Nielsen, Christian Heinis
Angewandte Chemie (2023) Vol. 136, Iss. 3
Open Access | Times Cited: 12
Short-Term Dorsal Genital Nerve Stimulation Increases Subjective Arousal in Women With and Without Spinal Cord Injury: A Preliminary Investigation
Elizabeth C. Bottorff, Priyanka Gupta, Giulia I. Lane, et al.
Neuromodulation Technology at the Neural Interface (2024) Vol. 27, Iss. 4, pp. 681-689
Closed Access | Times Cited: 4
Novel Pharmacologic Treatments of Female Sexual Dysfunction
Andrew How, Christopher Jowdy, Elli Novatcheva, et al.
Clinical Obstetrics & Gynecology (2025) Vol. 68, Iss. 1, pp. 10-14
Closed Access
Biased agonism in peptide-GPCRs: A structural perspective
Tharindunee Jayakody, Dinath Kavishka Budagoda, Krishan Mendis, et al.
Pharmacology & Therapeutics (2025), pp. 108806-108806
Open Access
Intravenous peptides and amino acids for erectile dysfunction: a narrative review of current applications and future directions
Vishal Ila, Edoardo Pozzi, Miyuru Gamage, et al.
Expert Opinion on Pharmacotherapy (2025)
Closed Access
Peptide Therapeutics: Current Status and Future Opportunity with Focus on Nose-to-Brain Delivery
Eva‐Maria Jülke, Annette G. Beck‐Sickinger
Peptides (2025), pp. 171404-171404
Closed Access
Page 1 - Next Page

Scroll to top